Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3353548)

Published in Aliment Pharmacol Ther on June 11, 2008

Authors

F L Lanza1, U K Marathi, B S Anand, L M Lichtenberger

Author Affiliations

1: Houston Institute of Clinical Research, Houston, TX, USA.

Articles citing this

Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol (2013) 1.10

NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol (2012) 1.03

Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine. Biochim Biophys Acta (2012) 0.97

Non-steroidal anti-inflammatory drug-induced enteropathy. Clin Endosc (2012) 0.93

Aggregation behavior of ibuprofen, cholic acid and dodecylphosphocholine micelles. Biochim Biophys Acta (2012) 0.82

Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges. Gastroenterol Res Pract (2013) 0.81

Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety. Gut Liver (2012) 0.80

Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation. Int J Mol Sci (2010) 0.78

Role of phospholipids in protection of the GI mucosa. Dig Dis Sci (2013) 0.78

Role of dietary phospholipids and phytosterols in protection against peptic ulceration as shown by experiments on rats. World J Gastroenterol (2015) 0.77

Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci. Physiol Rep (2016) 0.75

Convergence of nanotechnology and cancer prevention: are we there yet? Cancer Prev Res (Phila) (2014) 0.75

Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer. Mol Cancer Ther (2016) 0.75

Vaginal use of Ibuprofen isobutanolammonium (ginenorm): efficacy, tolerability, and pharmacokinetic data: a review of available data. ISRN Obstet Gynecol (2012) 0.75

Articles cited by this

Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA (2000) 20.35

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med (1999) 8.60

Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ (2005) 3.80

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med (2001) 3.02

GASTRIC MUCOSAL INJURY BY FATTY AND ACETYLSALICYLIC ACIDS. Gastroenterology (1964) 2.54

Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med (1995) 2.15

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum (1998) 1.79

Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med (2006) 1.71

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med (1998) 1.66

A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol (1998) 1.52

Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. Aliment Pharmacol Ther (1999) 1.24

Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem Pharmacol (1999) 1.04

Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem Pharmacol (2001) 1.01

Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury. Effect of scoring method. Dig Dis Sci (1990) 1.01

Aging, the gastrointestinal tract, and risk of acid-related disease. Am J Med (2004) 0.98

Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am J Gastroenterol (1999) 0.97

Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface. Analysis with a phospholipid-selective cytochemical stain. Gastroenterology (1990) 0.97

Global safety of coxibs and NSAIDs. Curr Top Med Chem (2005) 0.94

Aging and upper gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 0.88

Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently. Gut (1998) 0.82

NSAID ulcers: prevalence and prevention. Mod Rheumatol (2000) 0.79

Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis. Clin Rheumatol (2001) 0.78

Articles by these authors

(truncated to the top 100)

Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol (1997) 2.10

Aspirin concurrently administered with ranitidine does not delay healing of duodenal ulcer. Aust N Z J Med (1990) 2.04

Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats. Gastroenterology (2000) 1.76

Endoscopic sclerotherapy using absolute alcohol. Gut (1985) 1.73

Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats. Gastroenterology (1975) 1.61

Antibiotic properties of bovine lactoferrin on Helicobacter pylori. Dig Dis Sci (1998) 1.52

Role of surface-active phospholipids in gastric cytoprotection. Science (1983) 1.45

Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol (1983) 1.45

Conventional versus on-demand therapy for duodenal ulcer: results of a controlled therapeutic trial. Am J Gastroenterol (1990) 1.40

Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten. Lancet (1976) 1.31

The timing of histological damage following a single challenge with gluten in treated coeliac disease. Q J Med (1981) 1.29

Spectrum of acute poisoning in adults (10 year experience). J Assoc Physicians India (1984) 1.27

Pancreaticobiliary ductal union in biliary diseases. An endoscopic retrograde cholangiopancreatographic study. Gastroenterology (1989) 1.20

Rectal histology in acute bacillary dysentery. Gastroenterology (1986) 1.19

The role of various cereals in coeliac disease. Q J Med (1978) 1.19

Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel. Gastroenterology (1990) 1.18

Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut (1986) 1.16

Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa. Gastroenterology (1985) 1.08

Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel. Gut (1995) 1.07

Precipitins to different avaian serum antigens in bird fancier's lung and coeliac disease. Clin Allergy (1978) 1.07

Action of gastrin on gastrointestinal structure and function. Gastroenterology (1975) 1.07

Influence of endoscopic biopsy forceps characteristics on tissue specimens: results of a prospective randomized study. Gastrointest Endosc (1999) 1.06

Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer. Gut (1984) 1.06

An endoscopic method for removal of duodenal phytobezoars. Gastrointest Endosc (1995) 1.05

Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem Pharmacol (1999) 1.04

Skin test for coeliac disease using a subfraction of gluten. Lancet (1977) 1.04

Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma. Aliment Pharmacol Ther (2010) 1.03

Depression of antral and serum gastrin concentration by food deprivation in the rat. Gastroenterology (1975) 1.00

Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection. J Clin Gastroenterol (2001) 0.99

Repeated endoscopic sclerotherapy for active variceal bleeding. Ann Surg (1985) 0.98

Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am J Gastroenterol (1999) 0.97

Does aspirin damage canine gastric mucosa by reducing its surface hydrophobicity? Am J Physiol (1987) 0.97

Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface. Analysis with a phospholipid-selective cytochemical stain. Gastroenterology (1990) 0.97

Influence of geographical factors in the distribution of pathogenic zymodemes of Entamoeba histolytica: identification of zymodeme XIV in India. Trans R Soc Trop Med Hyg (1984) 0.97

Young v adult cirrhotics: a prospective, comparative analysis of the clinical profile, natural course and survival. Gut (1988) 0.96

Management of hepatocellular carcinoma. J Cancer Res Clin Oncol (2014) 0.96

Interaction of alcohol and hepatitis C virus infection on severity of liver disease. Dig Dis Sci (1999) 0.96

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*. J Viral Hepat (2006) 0.95

Duodenal ulcerogens, cysteamine and propionitrile, stimulate serum gastrin levels in the rat. Gastroenterology (1977) 0.95

Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. Am J Physiol (1983) 0.94

Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Gut (1987) 0.93

Amine trapping: physical explanation for the inhibitory effect of gastric acidity on the postprandial release of gastrin. Studies on rats and dogs. Gastroenterology (1986) 0.91

Importance of dietary amines in meal-induced gastrin release. Am J Physiol (1982) 0.91

Familial aggregation in noncirrhotic portal fibrosis: a report of four families. Am J Gastroenterol (1987) 0.90

Corrosive acid ingestion in man - a clinical and endoscopic study. Gut (1984) 0.90

Molecular association of trinitrobenzenesulfonic acid and surface phospholipids in the development of colitis in rats. Gastroenterology (1996) 0.89

Absorption of inorganic and haemoglobin iron in coeliac disease. Br J Haematol (1977) 0.89

Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects. Lancet (1984) 0.88

Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies. Dig Dis Sci (1993) 0.88

Spontaneous expulsion per rectum of an ileal lipoma. Postgrad Med J (1988) 0.87

In vitro recovery of canine gastric mucosal surface hydrophobicity and potential difference after aspirin damage. Dig Dis Sci (1995) 0.86

Importance of amino acid uptake and decarboxylation in gastrin release from isolated G cells. Nature (1982) 0.86

Low dose antacid therapy for duodenal ulcer. Indian J Gastroenterol (1983) 0.86

Major differences in the spectrum of gastrointestinal infections associated with AIDS in India versus the west: an autopsy study. Clin Infect Dis (1996) 0.86

Gastric acid secretion in patients with typhoid fever. Gut (1985) 0.86

Localization of phospholipid-rich zones in rat gastric mucosa: possible origin of a protective hydrophobic luminal lining. J Histochem Cytochem (1987) 0.86

Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci (1987) 0.86

Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight. Gut (1987) 0.85

A method to preserve extracellular surfactant-like phospholipids on the luminal surface of rodent gastric mucosa. J Histochem Cytochem (1990) 0.85

Development of carcinoma in chronic calcific pancreatitis. Int J Pancreatol (1990) 0.85

Neonatal gastric motility in dogs: maturation and response to pentagastrin. Am J Physiol (1979) 0.85

Invasive Helicobacter-like organisms in feline gastric mucosa. Helicobacter (1997) 0.84

Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats. Aliment Pharmacol Ther (1997) 0.84

Rats with gastritis have increased sensitivity to the gastrin stimulatory effects of luminal ammonia. Gastroenterology (1996) 0.84

Milk protection against experimental ulcerogenesis in rats. Dig Dis Sci (1987) 0.84

Sex-related difference in antral and serum gastrin levels in the rat. Proc Soc Exp Biol Med (1976) 0.84

Failure to isolate Helicobacter pylori from stray cats indicates that H. pylori in cats may be an anthroponosis--an animal infection with a human pathogen. J Med Microbiol (1997) 0.84

Pancreatic duct abnormalities in gall stone disease: an endoscopic retrograde cholangiopancreatographic study. Gut (1990) 0.83

Gastric mucosal barrier: hydrophobicity of stretched stomach lining. Am J Physiol (1985) 0.83

Use of micro samples of finger prick blood dried on filter paper for a quick and simple dipstick dot-EIA for diagnosis of amebic liver abscess (ALA). J Clin Lab Anal (1994) 0.83

Gastric emptying in the rat is inhibited by the duodenal ulcerogens, cysteamine and propionitrile. Gastroenterology (1977) 0.83

A role for milk phospholipids in protection against gastric acid. Studies in adult and suckling rats. Gastroenterology (1984) 0.82

Experimental examination of the direct damaging effects of Giardia lamblia on intestinal mucosal scrapings of mice. Trans R Soc Trop Med Hyg (1985) 0.82

Oesophageal ulceration after sclerotherapy--a complication or an accompaniment? Endoscopy (1986) 0.82

Altered gastrin regulation in mice infected with Helicobacter felis. Dig Dis Sci (2000) 0.81

Phosphatidylcholine-associated aspirin accelerates healing of gastric ulcers in rats. Dig Dis Sci (1998) 0.81

Bilirubin glucuronyl transferase activity in the human gastric and duodenal mucosa--a preliminary report. Indian J Med Res (1980) 0.81

Importance of food in the regulation of gastrin release and formation. Am J Physiol (1982) 0.81

Expression of intrinsic factor in rat and murine gastric mucosal cell lineages is modified by inflammation. Am J Pathol (2000) 0.81

Single intubation technique for the assessment of malabsorption and exocrine pancreatic function. Indian J Med Res (1980) 0.81

Gastric secretion in cirrhosis and non-cirrhotic portal fibrosis. Digestion (1988) 0.81

Study of lymphocyte sub-populations in Giardia infected mice. Ann Trop Med Parasitol (1981) 0.81

Transport studies and enzyme assays in mice infected with human Giardia lamblia. Trans R Soc Trop Med Hyg (1982) 0.80

Emergency upper gastrointestinal endoscopy in acute corrosive poisoning. Indian J Med Res (1980) 0.80

Phospholipid- and neutral lipid-containing organelles of rat gastroduodenal mucous cells. Possible origin of the hydrophobic mucosal lining. Gastroenterology (1991) 0.80

Amino acid- and amine-induced gastrin release from isolated rat endocrine granules. Am J Physiol (1991) 0.80

Bombesin prevents gastric injury in the rat: role of gastrin. Dig Dis Sci (1998) 0.80

Release of calcitonin by cultures of medullary carcinoma of the thyroid. Endocr Res Commun (1975) 0.80

Colonic myoelectrical activity in irritable bowel syndrome before and after treatment. Indian J Gastroenterol (1988) 0.79

Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection. Dig Dis Sci (2001) 0.79

Gastric mucosal hydrophobicity and Helicobacter pylori: response to antimicrobial therapy. Am J Gastroenterol (1993) 0.79

Factors influencing oesophageal ulcer formation following sclerotherapy. Indian J Gastroenterol (1987) 0.79

Sterol-dependence of gastric protective activity of unsaturated phospholipids. Dig Dis Sci (1990) 0.79

Jejunal mucosal morphology in healthy north Indian subjects. J Clin Pathol (1985) 0.79

Alterations in serum and antral gastrin levels in genetically diabetic mice. Gastroenterology (1979) 0.78

Effect of synthetic diets on gastrointestinal mucosal DNA synthesis in rats. Am J Physiol (1983) 0.78

Isoenzyme studies of Giardia lamblia isolated from symptomatic cases. Aust J Exp Biol Med Sci (1986) 0.78

Culture of Zollinger-Ellison tumor cells. Gastroenterology (1975) 0.78

Surface hydrophobicity of the gastric mucosa in the developing rat. Effects of corticosteroids, thyroxine, and prostaglandin E2. Gastroenterology (1988) 0.78

Comparative evaluation of indirect haemagglutination and immunofluorescence tests in serodiagnosis of giardiasis. Indian J Med Res (1981) 0.77